![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
Boston Pharmaceuticals
Boston Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing highly engineered therapies to transform the lives of patients who fight serious liver diseases.
WHO WE ARE - Boston Pharmaceuticals
We are a group of experienced pharmaceutical and biotech executives who are passionate about portfolio decision making to accelerate the pipeline of medicines to patients. Our portfolio is …
PIPELINE — Boston Pharmaceuticals
We are committed to developing effective treatments that address a broad array of diseases and conditions.
Home - Boston Group - Developing Solutions for a Sustainable …
At Boston Pharmaceutical Group, we offer specialized solutions across human pharmaceuticals, veterinary care, and cosmetics. Each division is tailored to meet the unique needs of our …
Boston Pharmaceuticals to Present Phase 2 Biopsy Results for
Oct 16, 2024 · CAMBRIDGE, Mass.-- (BUSINESS WIRE)-- Boston Pharmaceuticals, a clinical-stage biopharmaceutical company developing differentiated molecules addressing serious …
Boston Pharmaceuticals to Announce Positive Phase 2 Data on ...
Nov 15, 2024 · CAMBRIDGE, Mass.-- (BUSINESS WIRE)-- Boston Pharmaceuticals, a clinical-stage biopharmaceutical company developing differentiated molecules addressing serious …
Boston Pharmaceuticals - LinkedIn
Transforming the right molecules into the best medicines™ Boston Pharmaceuticals acquires and transforms innovative molecules into differentiated medicines that improve patients’ lives. We …
Boston Pharmaceuticals 2025 Company Profile: Valuation, …
Operator of a drug development company intended to acquire clinical assets at various stages of their development.
Boston Pharmaceuticals to Present Phase 2 Biopsy Results for …
CAMBRIDGE, Mass., October 16, 2024 -- (BUSINESS WIRE)-- Boston Pharmaceuticals, a clinical-stage biopharmaceutical company developing differentiated molecules addressing …
Boston Pharmaceuticals to Announce Positive Phase 2 Data on ...
CAMBRIDGE, Mass., November 15, 2024 -- (BUSINESS WIRE)-- Boston Pharmaceuticals, a clinical-stage biopharmaceutical company developing differentiated molecules addressing …